Murdo Gordon has been Bristol-Myers Squibb’s Chief Commercial Officer since June, 2016. He is responsible for leading the execution of commercial strategy across the globe. This includes all sales and marketing activities as well as customer operations, access and pricing. Prior to becoming CCO, Murdo served as head of worldwide markets with responsibility for the promotion of all BMS brands in over 65 global markets. This was preceded by his work as president of BMS’ US operations; a role he assumed in 2013. Murdo maintains an active interest in global and U.S. health care policy and how different stakeholders can improve the efficiency and cost effectiveness of health care delivery. He is a member of the Board of Directors of RWJBarnabas Health and received a BSc in Cell and Molecular Biology from Concordia University, Montreal. Murdo also attended the General Management Program, CEDEP at INSEAD, Fontainebleau, France.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.